Children with neurofibromatosis (NF1) typically develop central nervous system (CNS) abnormalities, including aberrant proliferation of astrocytes and formation of benign astrocytomas. The NF1 gene encodes neurofibromin, a Ras-GAP, highly expressed in developing neural cells; the mechanism of regulation of neurofibromin as a Ras-GAP, remains however unknown. We now show that, in response to EGF, neurofibromin is in vivo phosphorylated on serine residues by PKC-a, in human, rat, and avian CNS cells and cell lines. EGF-induced PKC phosphorylation was prominent in the cysteine/serine-rich domain (CSRD) of neurofibromin, which lies in the Nterminus and upstream of the Ras-GAP domain (GRD), and this modification significantly increased the association of neurofibromin with actin in co-immunoprecipitations. In addition, we show that Ras activation in response to EGF was significantly lowered when C62B cells overexpressed a construct encoding both CSRD þ GRD. Moreover, when PKC-a was downregulated, the Ras-GAP activity of CSRD þ GRD was significantly diminished, whereas overexpressed GRD alone acted as a weaker GAP and in a PKC-independent manner. Most importantly, functional Ras inhibition and EGF signaling shifts were established at the single cell level in C6-derived cell lines stably overexpressing CSRD þ GRD, when transient co-overexpression of Ras and PKC-depletion prior to stimulation with EGF-induced mitosis. Taken together, these data provide the first evidence of a functional, allosteric regulation of GRD by CSRD, which requires neurofibromin phosphorylation by PKC and association with the actin cytoskeleton. Our data may suggest a novel mechanism for regulating biological responses to EGF and provide a new aspect for the understanding of the aberrant proliferation seen in the CNS of children with NF1.
Introduction
The NF1 gene on human chromosome 17q (Cawthon et al., 1990; Wallace et al., 1990) encodes the 2818 amino-acid neurofibromin protein, containing an Nterminus cysteine/serine-rich domain (CSRD), a 360 amino-acid region (NF1-GRD) with homology to the mammalian p120-Ras-GAP, a leucine-repeat domain upstream of the extreme carboxyl terminus domain (Martin et al., 1990) , and a C-terminal helical domain containing a functional nuclear localization sequence (NLS-CTD) (Li et al., 2001; Vandenbroucke et al., 2004) . NF1-GRD, an active Ras-GAP in vivo and in vitro, is able to reverse tumorigenic properties of NF1-deficient cells and therefore neurofibromin is classified as a tumor suppressor gene (Yan et al., 1995; Hiatt et al., 2001) . The function, however, of the other domains is little understood and their possible allosteric regulation on GRD remains unknown. Mutations in the NF1 gene cause neurofibromatosis (NF1), or von Recklinghausen's disease, the most common, dominantly inherited disorder of the nervous system. In the developing brain, typical NF1-associated central nervous system (CNS) abnormalities include specific learning disabilities and benign pilocytic astrocytomas (Friedman et al., 1999) . These may be attributed to an aberration in neuronal differentiation and astrocytic proliferation, respectively. In addition to Ras-GAP function, recent studies have implicated neurofibromin in PKA/cAMP pathway signaling in the mouse and Drosophila, where loss of NF1 negatively regulates forskolin-dependent adenylate cyclase activity (Tong et al., 2002) . These observations collectively support the notion that neurofibromin regulation of cell growth and differentiation may involve the convergence of multiple signaling pathways.
Growth factor receptor signaling regulates the temporal and spatial patterns of proliferation, differentiation, and migration of neurons and astrocytes, which result in the genesis and later in the maintenance of the brain's intricate anatomy and physiology. The prototypical growth factor-tyrosine kinase receptor, epidermal growth factor receptor (EGFR), has been shown to stimulate all these cellular processes. EGFRs stimulate mitosis in clonally derived, highly expandable neural stem cells and cell lines (Kornblum et al., 1999; Cheng et al., 2000a; Represa et al., 2001) , regulate neural cell movement and migration (Burrows et al., 1997; Duchek and Rorth, 2001) , and modulate neural cell differentiation and survival (Threadgill et al., 1995; Sibilia et al., 1998) . Moreover, depending on the developmental status of the cell, the integrated biological response to EGFR-activated concurrent signaling cascades may vary widely from migratory to proliferative (Chen et al., 1996; Cheng et al., 2000a; Shiraha et al., 2000) . This dual role of EGFR in specifying cell proliferation versus motility is thought to depend on the balance between robust activation of the mitogenic Ras pathway or the concurrently activated PLC-g pathway (Xie et al., 1998) , which initiates a protein kinase C (PKC)-mediated negative feedback on Ras (Chen et al., 1996) . These observations have implicated PKC-protein substrates, in particular proteins involved in actin-dependent cell motility, as modulators of the biological outcome of EGFR signaling (Chen et al., 1996; Shiraha et al., 2000) .
Our previous confocal analysis studies of cortical neurons and astrocytes have demonstrated that neurofibromin, which is upregulated during brain differentiation and cessation of proliferation (Brannan et al., 1994; Gutmann et al., 1995; Li et al., 2001) , colocalizes with the cortical F-actin (Li et al., 2001) . F-actin networks are important in immature neurons for neuritic elongation, neuronal migration, and regulated secretion (Cheng et al., 2000a) . Disruption of the cortical F-actin cytoskeleton affects the translocation of exocytotic vesicles to the plasma membrane, a process that requires PKC activation and phosphorylation of F-actin-binding proteins (Rose et al., 2001) . Analysis of the primary structure of neurofibromin reveals several PKC phosphorylation consensus sites. In addition, both Ras and PKA pathways affect activation of Raf-1, a kinase that requires PKC activation (Wu et al., 1993) . With this background, we undertook these studies to investigate the potential role of EGFR-dependent, PKC phosphorylation of neurofibromin in neurofibromin's Ras-GAP function and subsequently in the biological outcome of EGF signaling in neural cells.
Results and discussion

PKC activation-induced neurofibromin phosphorylation in neural cells
The phorbol ester tetradecanoyl phorbol acetate (TPA), a direct activator of PKC, caused a rapid increase in the in vivo incorporation of [ 32 P]-orthophosphate into neurofibromin in telencephalic neurons from embryonic day 6 (E6) at two different stages of development in culture, 2-day-old cultures (C2) and 7-day-old cultures (C7), respectively, and in the rat C62B astrocytoma cell line as shown by autoradiography (Figure 1a) after SDS-PAGE analysis of immunoprecipitated neurofibromin (Figure 1b) .
PKC-dependent phosphorylation of neurofibromin in neurons was detectable by 1 min of exposure, maximal at 2 min and had started declining by 5 min (Figure 1a and c), returning to basal levels thereafter (data not shown). When analyzed in lower percentage gels (i.e., 7 (Figure 1a ), versus 4% (Figure 1c) ) neurofibromin appeared as a double band in E6C2 neurons (Figure 1c ), which could possibly indicate that in younger neurons a subpopulation of neurofibromin protein species is heavily phosphorylated. Analysis of the primary structure of neurofibromin for PKC ]-orthophosphate incorporation in neurofibromin, in C62B rat astrocytoma cells and primary neurons from 6-day chick embryo telencephalon (E6) grown in culture for 2 (C2) or 7 days (C7). Cell lysates were immunoprecipitated with neurofibromin antibodies, and immunoprecipitates were analyzed by SDS-PAGE and dried gel autoradiography. Panel a contains a typical autoradiogram of immunoprecipitated neurofibromin and panel b is the image of Coommassie stain of the same SDS gel (7% polyacrylamide) prior to drying. (c) The magnitude of response appeared developmentally regulated and was higher in immature neurons E6C2 than in differentiated E6C7 neurons (autoradiography of 4-12% gradient gels). The response was completely abolished by the PKC inhibitor chelerythrine chloride (CC, 5 mM), but not by the peptide PKA inhibitor pPKAi (10 ng/ml). (d) Statistical evaluation of these counts confirmed the autoradiography data. In all experiments corresponding gels areas were excised and [ PKC phosphorylates neurofibromin D Mangoura et al phosphorylation consensus sites (PROSITE) identifies 45 such putative phosphorylation sites, 13 on threonine and 32 on serine residues. Most phosphorylation consensus sites are located within the N-terminus of neurofibromin and, in particular, in the cysteine-rich domain CSRD of neurofibromin. Therefore, concomitant phosphorylation of most of these sites could explain the increase in M r seen in low percentage SDS gels (Figure 1c, E6C2) . Interestingly, the precise amino-acid sequence of endogenous neurofibromin has not yet been defined, nor possible post-translational modifications have been identified. Therefore, it is feasible that the post-translational modification of phosphorylation of neurofibromin may also facilitate other such modifications that alter its electrophoretic mobility. Phosphorylation was specifically induced by PKC, as it was completely abolished in the presence of chelerythrine chloride (CC in Figure 1c ), a potent and specific over other kinases inhibitor of PKC (Chen and Exton, 2004) . In contrast, the PKA inhibitor pPKAi had minimal effects ( Figure 1c ). An identical time course and pharmacological inhibition profile of PKC-dependent phosphorylation of neurofibromin was also seen with activation of the EGFR (Figure 1c) , which is coupled to PKC activation via PLC-g. Levels of neurofibromin phosphorylation were higher in C62B astrocytoma and in immature neurons (E6C2) than in differentiated neurons (E6C7) (arrows in Figure  1a and c, and quantitation by scintillation counting in Figure 1d ), reaching a sevenfold increase in the two former as compared to a fourfold in the latter. These differences may reflect the known high expression of PKC-a in C62B (Brodie et al., 1998) , as well as the coupled downregulation of PKC-a and upregulation of PKC-e which occurs between these two stages of neuronal development (Mangoura and Dawson, 1993; Li et al., 2001) . Thus, these data indicated a high substrate specificity of the Ca 2 þ -dependent PKC-a isoform for neurofibromin.
Furthermore and in accordance with the PROSITE analysis prediction that the majority of PKC consesus sites involve serine residues, we found that increases in PKC phosphorylation were primarily contributed by phosphorylated serine residues. Specifically, in experiments where neurofibromin immunoprecipitates were split in half and each half was analyzed with autoradiography ( Figure 2a , a typical SDS gel stained with Coommassie blue; b, autoradiogram of a) or Western blotting with anti-phosphoserine mAb (Figure 2c ), we observed similar gains in phosphorylation. Antibodies specific to phosphothreonine did not recognize immunoprecipitated neurofibromin (data not shown). Taken together these data (Figures 1 and 2 ) strongly indicate that neurofibromin was phosphorylated preferably by the Ca 2 þ -dependent PKC-a isoforms on serine residues in response to EGF in embryonic neurons and C6 astrocytoma cells. The precise position of the phosphorylated residues will have to be identified with tandem mass spectrometry.
PKC-dependent phosphorylation of neurofibromin induces its association with actin
In these experiments we investigated in primary neuronal cultures and in several neural cell lines a previously indicated association of neurofibromin with actin (Li et al., 2001) , as well as a possible regulation of this association by PKC-dependent phosphorylation of neurofibromin. For this purpose, we examined whether b-actin co-immunoprecipitated neurofibromin in immature E6C2 neurons (Figure 3a and b) in the human neuroblastoma cell line SH-SY5Y (Figure 3c and d) , and in C62B rat astrocytomas (Figure 3e and f) . In all cell types examined we found that exposure to TPA or EGF increased the amount of neurofibromin that coimmunoprecipitated with b-actin. Specifically, 1 mg of total cell lysate was immunoprecipitated with 1 mg of anti-b-actin monoclonal mouse IgG1 and immunoprecipitates were analyzed by SDS-PAGE and Western blotting ( Figure 3a , c and e). Probing the upper part of membranes with the antibodies to neurofibromin and the lower with the anti-b-actin IgG1, revealed that recovery of actin remained constant with time of treatment with TPA, whereas the number of neurofibromin molecules that were complexed with actin significantly increased by over three-fold (by densitometry Figure 3b, d and f) .
In all these cell types tested, neurofibromin's association with actin was temporally regulated in the same pattern as PKC-dependent phosphorylation. EGF stimulation also increased the association of neurofibromin with actin in a PKC-dependent manner (inhibited by chelerythrine, CC, but not pPKAi), in a more potent manner than TPA (Figure 2d , example shown in C62B cells). Therefore, neurofibromin associates with This association with actin is in accordance with our previous data from confocal analysis in immature neurons, where the neurofibromin colocalization with F-actin is differentiation-dependent, being prominent in immature primary neurons, but not in mature neurons; in both cases it is also localizes in the nucleus (Li et al., 2001) . The primary sequence of neurofibromin does not contain any actin or other cytoskeleton protein-binding domains, and thus the nature of the association remains unclear. There are, however, several classes of proteins that associate with membrane-associated GTPases, contribute to nuclear activities, and, in addition, associate with actin in a phosphorylation-dependent manner, for example, the diaphanous proteins that can physically link the actin filament system with Rho GTPases (Frazier and Field, 1997) . Moreover, myopodin, another tumor suppressor gene product with an nuclear localization signal (NLS), may shuttle between cytoplasm, cortical cytoskeleton and the nucleus depending both on the differentiation status of myocytes and myoblasts and phosphorylation. With a recently established novel mechanism, 14-3-3 proteins recognize and bind phosphorylated serine residues, which renders the NLS domain accessible to importin a resulting in the nuclear import of myopodin (Faul et al., 2005) . Finally, the activity of MAL protein, a signal-regulated coactivator of the transcription factor SRF, which also co-immunoprecipitates with actin, has been recently shown to be controlled by a mechanism in which activation of actin polymerization by Rho induces its redistribution from the cytoplasm to the nucleus (Miralles et al., 2003) . A similar complex regulation is expected for the shuttling of neurofibromin within neurons to explain its apparent association with Ras after membrane receptor signaling and therefore its phosphorylation-dependent association with actin may help identify the signaling complexes that neurofibromin participates in, after growth-factorreceptor activation. 
EGF induces PKC-dependent phosphorylation of the N-terminus, CSRD domain of neurofibromin
Since EGF stimulated PKC-dependent phosphorylation of neurofibromin, we sought to investigate whether this previously uncharacterized molecular post-translational modification of this Ras-GAP had a functional role in EGFR-dependent Ras activation, as well as to verify the role of PKC-a in neurofibromin phosphorylation. As discussed above, PROSITE analysis shows that most PKC phosphorylation consensus sites are located within the N-terminus cysteine-rich domain of neurofibromin, CSRD, whereas the GRD domain is almost devoid of such sites. Therefore, we constructed pcDNA3.1-myc/ HIS plasmids containing hNF1GRD expressed as a 50 kDa protein product, or GRD with the upstream N-terminus CSRD of human neurofibromin, expressed as a 180 kDa protein (Marchuk et al., 1991) , and separately overexpressed them by transient transfections in C62B astrocytoma cells, as described in the Materials and methods. We first examined whether PKC activators increased phosphorylation on sites on the CSRD þ GRD protein, using dried gel autoradiography of immunoprecipitations with the polyclonal SC068 to neurofibromin of 32 P-labeled cells (Figure 4a ), after resolving immunoprecipitates with SDS-PAGE (Figure 4b ). Both TPA and EGF increased phosphorylation of the 180 kDa NF1CSRD þ GRD protein in a time-dependent manner (Figure 4a ), whereas no phosphorylation increase was established for the 50 kDa products of any of the GRD plasmids (not shown). Analysis of the pharmacological profile of the EGFdependent phosphorylation of the CSRD þ GRD protein using several inhibitors specific to individual PKC isoforms suggested that this event was PKC-dependent ( Figure 4a ). The relatively specific inhibitor for Ca 2 þ -dependent (conventional) PKC isoforms a and b (Chodniewicz et al., 2004 and refs) Go¨6976 abolished any phosphorylation, as well as long pretreatment of the cells with (100 nM) TPA for 24 h, a well-established pharmacological method for downregulation of the conventional PKC isoforms, whereas inhibition of the other major PKC isoform in C62B cells, Ca 2 þ -independent PKC-d (Brodie et al., 1998) , by rottlerin (Corbit et al., 1999; Chodniewicz et al., 2004) or by pretreatment with antisense oligonucleotides to PKC-d (Corbit et al., 1999) , had no significant effects on the phosphorylation of the CSRD þ GRD neurofibromin fragment (Figure 4a ). The phosphorylation profile of CSRD þ GRD appeared identical to that of full length, endogenous neurofibromin (the fainter band at B230 kDa), which also immunoprecipitated with SC068 antibodies. Complete downregulation of PKC-a with prolonged exposure to TPA (24 h Â 100 nM) is shown in the left panel in Figure 4c . The other two Ca 2 þ -dependent PKC isoforms b and g are expressed in very low levels in C6 and do not downregulate with longterm TPA (Brodie et al., 1998) . Downregulation of PKC-d, with prolonged exposure to its specific antisense ODN, is shown in the right panel in Figure 4c . Taken together these data suggest that both native neurofibromin and its N-terminus, where a high incidence of mutations have been identified in neurofibromatosis 1 patients (Fahsold et al., 2000) , were preferred PKC-a substrates.
Ras-GAP activity of neurofibromin is regulated by PKCdependent phosphorylation of CSRD We then examined the potential effect of PKC phosphorylation of CSRD on its Ras-GAP activity. GTP-Ras (activated Ras) was affinity precipitated from equal amounts of cell lysate protein (Figure 5a ), using the Ras-binding domain of Raf (GST-RBD) as a GSTfusion protein immobilized on S-hexylglutathione-agarose beads (Figure 5b) , as described in the Materials and (Figure 5b, lanes 1-3) , exposure to EGF for 5 min elicited increased levels of activated Ras in cells with active (lane 2) or downregulated PKC-a after 24 h exposure to TPA (lane 3). Given the low expression of Ras in C62B as compared to other tumor-derived cell lines and the overexpression of fragments with Ras-GAP activity, in order to achieve better stoichiometry for regulation of Ras we transiently co-overexpressed wild-type Ha-Ras (lanes 4-6) with hNF1GRD (lanes 7-9) or with hNF1CRSD þ GRD (lanes 10-12) . Ras activation by EGF was clearly demonstrated in cells overexpressing Ras (lane 5 and 6) than in naı¨ve cells. Downregulation of classic Ca 2 þ -dependent PKCs by prolonged TPA exposure (lane 6), which for C6 cells corresponds to PKC-a as discussed above, did not affect EGF-induced Ras activation. When cells co-overexpressed GRD and Ras, we observed a small but significant decrease in Ras activation in response to 5 min EGF treatment (lane 8 compared to lane 5). Again downregulation of PKC-a the major Ca 2 þ -dependent PKC isoform in C6 cells had no additional effect (lane 9 versus 8). These findings suggested that the GRD region alone was not maximally effective as a Ras-GAP, and that PKC phosphorylation does not modulate the weak Ras-GAP activity of the isolated GRD, which may possibly be targeted in a suboptimal manner within the cell. In contrast, cooverexpression of CSRD þ GRD and Ras resulted in a significant 30% downregulation of EGF-stimulated Ras activation (lane 11 compared to lane 5); and in a significant downregulation as compared to stimulation when GRD was overexpressed (lane 11 compared to lane 8). Most profound, however, was the finding that prior inhibition of PKC by chronic TPA treatment resulted in a reduced Ras-GAP activity of CSRD þ GRD and a significant increase in activation of Ras by EGF (lane 12 versus lanes 5, 8, and 11).
Overexpressed Ha-Ras undergoes the regular posttranslational modifications of farnesylation of the CAAX cysteine, proteolytic removal of the AAX amino acids and methyl esterification of the new C-terminal prenylcysteine, and palmitoylation, in the same sequence as the endogenous, and readily becomes activated in response to growth factors (Chiu et al., 2002) . Our data also show that overexpressed H-Ras is engaged normally in the EGF signaling pathway, and therefore suggest that the observed differences derived from the overexpression of the GRD or CSRD þ GRD fragments, respectively. Moreover, the important finding that the NH 2 -terminal part of neurofibromin CSRD þ GRD conferred greater regulation on Ras suggested that it may be mediated by CSRD. When PKC phosphorylation of CSRD by conventional PKC was not possible due to downregulation with long-term TPA, the CSRD þ GRD protein did not sufficiently function as a GAP and subsequently Ras activation was significantly enhanced.
Thus, it appears that PKC-phosphorylation of residues beyond the GRD region and within the CSRD region may serve to target neurofibromin, possibly through interactions with the actin cytoskeleton, in order to maximize its Ras-GAP function. This is in accordance with several studies showing that the effect of the prototypic GAP protein p120 as a negative regulator of Ras is commenced by protein-protein interactions through its various noncatalytic domains (Martin et al., 1992; Schweighoffer et al., 1992; Clark et al., 1993 Clark et al., , 1997 Drugan et al., 2000) . This allosteric effect of the noncatalytic domains on the GAP activity was demonstrated when overexpression of sequences from the NH 2 -terminal region of p120 GAP (N-GAP), excluding the Ras-interacting catalytic domain, modulated Ras signaling. Such regulatory roles have also been postulated for GAPs acting on heterotrimeric G proteins (Chidiac and Ross, 1999) and the Rho family GAP (Kuroda et al., 1996) . Although the nature of these interactions remains unclear, evidence from studies addressing RACK1 binding to Ras-GAP, has showed that serine/threonine phosphorylation is involved in regulating these protein interactions (Koehler and Moran, 2001) . Our data also show that there is an allosteric effect of the noncatalytic CSRD of neurofibromin on its GAP domain at least in neural cells. Cultures were transfected and treated as indicated, and total cell homogenates only from cultures overexpressing equal amounts of Ras, lanes 4-12, were selected for affinity precipitation with GST-RBD shown in (b). (b) GTP-Ras was purified using GST-RBD immobilized on S-hexylglutathione-agarose beads; the precipitated GTP-Ras was also identified using Western blotting with anti-Ras mAb. Endogenous Ras (lanes 1-3) was activated by EGF (lanes 2 and 3) in a manner independent of prior PKC-a downregulation (kPKC-a) with long-term TPA (lane 3). Similar pharmacological regulation was seen with overexpressed wt-Ras (lanes 4-6). Compared to wt-Ras overexpression alone, co-overexpression of GRD resulted in reduced GTP-Ras after EGF stimulation (lanes 7 and 8). GTP-Ras level was even lower when cells overexpressed CSRD þ GRD (lane 11). Most importantly, when PKC-a was depleted, GTP-Ras level was significantly elevated (lane 12). Relevant statistical comparisons for Ras activation after 5 min of EGF using mean densitometry values from 5 different experiments: wt-Ras þ GRD7kPKC-a owt-Ras (lanes 8 or 9 versus 5 or 6) Po0.02; wt-Ras þ CSRD þ GRD owt-Ras (lane 11 versus 5) Po0.01; wt-Ras þ GRD> wt-Ras þ CSRD þ GRD (lane 8 versus 11) Po0.02; and, wt-Ras þ CSRD þ GRD þ kPKC-a >wt-Ras7kPKC-a (lane 12 versus 5 or 6) Po0.001.
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Mitotic EGF signaling shifts in C62B stable transfectants of the N-terminus of neurofibromin with cooverexpression of Ras and PKC downregulation Finally, we examined whether the observed decrease in Ras-GAP activity of CSRD þ GRD overexpressing cells was adequate to change the biological outcome of EGF signaling in C62B cells (Figure 6 ). When examined several hours (4-8) after stimulation, EGF is not a mitogen in serum-starved astrocytes or wild-type-C62B cells (Goya et al., 1996; Fricker-Gates et al., 2000) and, through activation of Src/Ras and sustained activation of ERK, may increase their motility (Chen et al., 1996; Fricker-Gates et al., 2000) even when cells overexpress Ras Tompa, Soc. Neurosci. 26: 1069, 2001 (Figure 6a ), nor spontaneous cell proliferation in serum-starved cultures with occurrence of mitotic nuclei remaining the same (arrow in Figure 6b points to a cytokinesis), as revealed with DAPI staining (Crespo et al., 2002) . Transient overexpression of Ras after transfection with pCMV5-Ras in this myc/HIS/ CSRD þ GRD-C62B cell line was identified as a multifold increase in fluorescence after immunostaining with Ras antibodies (arrows in Figure 6c with 2 s of exposure and C 0 with 1 s). Specifically the average intensity of Ras fluorescence per cell of 28.372 was increased to 152.2717.8 with transfection (representative images of untransfected and transfected cells are shown with arrowheads and arrows, respectively, in Figure 6c ). As with pCMV5, transient overexpression of Ras did not affect the low spontaneous cell proliferation and mitotic figures were only occasionally seen in untransfected cells (arrowhead in Figure 6d points to spontaneous telophases in a cell that does not overexpress Ras). In fact, overexpression of Ras was commonly associated with differentiated morphology (arrows in Figure 6c and c 0 ), features also observed with overexpression of Ras in wild-type cells Tompa, Soc. Neurosci. 26: 1069, 2001 ). Moreover, CSRD þ GRD-C62B cells co-overexpressing Ras (Figure 6e , arrows) behaved as naı¨ve C62B, and did not divide in response to 5 h (long term) EGF signaling (Figure 6f , arrows point to nuclei of the cells indicated in E). However, when PKC-a was downregulated with 24 h exposure to TPA prior to stimulation with EGF for 5 h, and the ability to phosphorylate CSRD þ GRD was lost, co-overexpression of Ras (numbers 1-7 in Figure 6g indicate such cells) led to a significant increase in cell proliferation (numbers in Figure 6h identify the nuclei of cells 1-5 as in metaphase, 6 in telophase and 7 in cytokinesis). No increases in proliferation were recorded in untransfected or mock-transfected cells (Figure 6i , quantification of results).
Signaling through the EGFR has been shown to regulate astrocyte motility (Fricker-Gates et al., 2000) and EGFR-null mice or mice with targeted EGFR disruption have impaired astrocytic differentiation (Threadgill et al., 1995; Sibilia et al., 1998) . This has been postulated to result from activation of the PLC-g pathway and disruption of ERK activation, leading to enhanced motility instead of enhanced proliferation. This feedback attenuation is known to occur via activation of PKC (Chen et al., 1996) . Our results suggest that neurofibromin may be part of this PKCdependent feedback mechanism as it impacts on Ras activation, an upstream effector of ERK activation.
In this study, we provide the first evidence that PKC activation in neurons and astrocytes results in neurofibromin serine phosphorylation, increases in neurofibromin association with the actin cytoskeleton, and increased Ras-GAP function. These posttranslational modifications occur with activation of PKC by EGF. Moreover, we show that EGF-dependent stimulation of Ras was decreased by neurofibromin GAP activity and that this regulation required activation of PKC, primarily PKC-a, and phosphorylation of serines upstream of the GRD region and in the CSRD N-terminus domain. Stimulation with EGF may cause regulation of F-actin-dependent cell processes, that is, migration, or cell proliferation through robust activation of PLC-g, PKC, and Ras, respectively. These two pathways are often concomitantly activated and has been suggested that a PKC-mediated feedback mechanism may shift the response from proliferation to migration. Based on the results described herein, we propose that PKC phosphorylation of neurofibromin may serve to increase Ras-GAP function and to promote cell growth arrest and actin cytoskeleton-associated functions instead of cell proliferation in response to pleiotropic growth factors. These observations may also provide new insights into the contribution of neurofibromin dysfunction to the learning disabilities and astrocytoma formation in children with NF1.
Materials and methods
Materials
Antibodies to C-(067) or N-terminus (068) of neurofibromin, which equally recognize full-length neurofibromin and a mouse monoclonal (mAb) 9E10 against myc and HIS were obtained from Santa Cruz Biotechnology; mAbs for the actinb isoform and for phosphoserine or phosphothreonine residues were purchased from Sigma; mAbs against Ha-Ras were from Transduction Laboratories and Santa Cruz. All other antibodies were purchased from Jackson Immunoresearch Laboratories. PKC inhibitors Go¨6976 and rottlerin were from Calbiochem, chelerythrine chloride from and PKA-specific inhibitor pPKAi were from Alexis and Santa Cruz, respectively.
Cell culture
Primary cultures of E6 telencephalic neurons were prepared by mechanical dissociation and maintained in chemically defined medium, as previously described (Mangoura, 1997; Cheng et al., 2000b) ; C62B rat astrocytoma cells were also cultured as previously reported by us (Mangoura and Dawson, 1998) ; and human neuroblastoma cell lines IMR32 and SH-SY5Y were purchased from ATCC and cultured as instructed. For all experiments involving stimulation with human or murine EGF (Invitrogen) or TPA (Alexis) specific concentrations or times are stated per experiment. Cell cycling was arrested by serum starvation (serum-free medium plus 0.1% bovine serumalbumin) for an average of 24 h before treatments.
Immunoprecipitation and Western blot analyses
Immunoprecipitations were performed as described previously (Mangoura, 1997; Cheng et al., 2000a, b) . Briefly, cells were treated with agonists and or antagonists as indicated per experiment, and lysed in a 10 mM Tris-HCl pH 7.4 buffer containing 50 mM NaCl, 5 mM EDTA, 50 mM NaF, 1 mM Na 3 VO 4 , 10 nM okadaic acid, and 1% Triton X-100 with two protease inhibitors, leupeptin and Ep459 at 10 mg/ml. After removal of insoluble material (10 000 r.p.m. for 10 min at 41C), supernatants were assayed for protein content with the DC Biorad kit (Biorad). Equal amounts of lysates were precleared by incubation with normal rabbit IgGs conjugated to protein-A-agarose (UBI), supernatants were then incubated with antibodies against neurofibromin and immunocomplexes were recovered by protein-A-conjugated agarose beads. For immunoprecipitations with a mAb to actin, both preclearing and collection of the immunocomplexes was done with rabbit-antimouse also conjugated to protein-A-agarose beads. Immunoprecipitates were analyzed by SDS-PAGE (in 7% linear gels or 4-12% or 7-16% gold cast gradient gels) and by Western blotting with the indicated antibodies and the appropriate species-specific secondary antibodies conjugated to horseradish peroxidase or to alkaline phosphatase (AP) (Mangoura, 1997; Cheng et al., 2000b) . Immunoreactivity was visualized by further incubation with ECL chemiluminescence (Pierce) or with the AP Substrate kit (Biorad). For immunoprecipitated neurofibromin, densitometry curves from silver staining and Western blotting showed that detection was linear from 200 to 2000 mg of total cell lysate. In experiments with total cell lysates, increases in luminescence were linear from 30 to 80 mg of total cell lysate protein/lane for 5 min of exposure for neurofibromin and from 20 to 50 mg per lane for 10 s of exposure for the other antibodies. Exposed films or stained membranes were then scanned using the Kodak digital science Electrophoresis Documentation and Analysis system 120, and densitometry analysis was performed with the densitometry software NIH Image 1.62.
In vivo phosphorylation of neurofibromin
Labeling of live cells in culture was performed as previously reported (Mangoura and Dawson, 1993; Cheng et al., 2000a) . Briefly, 100 mCi [ 32 P]-orthophosphate/60 mm culture dish was added 3 h prior to addition of PKC or PKA kinase inhibitors for additional 30 min and subsequent treatment with agonists.
Cells were stimulated with either (100 ng/ml) EGF or (100 nM) TPA for times indicated. [
32 P]-orthophosphate incorporation into neurofibromin was assayed by immunoprecipitation of neurofibromin as described above, SDS-PAGE analysis, Coommassie blue or silver staining to assure equal loading, and dried gel autoradiography. Finally, gel areas corresponding to neurofibromin were excised, [
32 P] was quantitated by scintillation counting, and neurofibromin phosphorylation was expressed as c.p.m. of transferred phosphate to neurofibromin protein immunoprecipitated from 1 mg total cell protein Dawson 1993, 1998; Cheng et al., 2000a, b) . Phosphorylation of immunoprecipitated neurofibromin was also quantitated with Western blot using phospho-amino-acidspecific antibodies and densitometry (as described above).
Plasmid constructs and antisense oligonucleotides (ODNs) Neurofibromin fragments containing either Type I or II transcript of the GRD region (Marchuk et al., 1991) were amplified from freshly isolated human neuroblastoma (IMR32) RNA by PCR using the same set of sense and antisense primers (NF1 nt 3463-4671); the amplified DNA was then cloned into pGEM (Invitrogen) and subcloned into the multiple cloning site of Not/HindIII-digested pcDNA3.1-myc/ HIS mammalian expression vector (Promega). In pilot experiments no differences were seen with proteins expressed from pcDNA3.1myc/HIS/GRDI or pcDNA3.1myc/HIS/ GRDII constructs or with a second set of GRDI and II plasmids containing nt 3372-4612 and cloned into a different vector, pRME-GRD. The CSRD þ GRDII fragment of neurofibromin, which contains nt À200 to þ 4843 (or HF3A, see Marchuk et al., 1991) , was used either in the pRME vector (DHG) or in pcDNA3.1myc/HIS after subcloning in the HindIII site (plasmid pcDNA3.1myc/HIS/CSRD þ GRD). In all cases, cloning was verified by restriction site mapping and automatic sequencing (Cancer Research Center DNA Sequencing Facility, University of Chicago). Plasmids pCMV5-HaRas, pCMV5 (empty vector), and GST-c-Raf-1 Ras-binding domain (GST-RBD) were kindly provided by Dr Itoh (Tokyo Institute of Technology) (Edamatsu et al., 1998) . Phosphorothioate-modified ODNs were synthesized in the Howard Hughes Facility, The University of Chicago. The antisense sequence for PKC-d 5 0 -GAA-GGA-GAT-GCG-CTG-GAA-3 0 (Corbit et al., 1999) and the sense sequence, serving as a control, were used to treat cells in culture as previously described by us (Cheng et al., 2000b) . Briefly, 70% confluent cells were incubated with 10 mM ODN/10 mg/ml Lipofectin (GIBCO, Life Technologies) for 4 h and then with 10 mM ODN without Lipofectin for 24-36 h.
Measurement of GTP-bound state of Ras
Cells were transfected with indicated plasmid DNAs (5 mg/ 35 mm culture dish) using Effectene (Qiagen), as instructed by PKC phosphorylates neurofibromin D Mangoura et al the manufacturer. The total amount was adjusted to 17 mg/ 35 mm dish with empty vector (pCMV5). The medium was replaced 18-24 h after transfection and then cells were starved with 1 mg/ml bovine serum albumin (Fisher) in serum-free medium for another 24-36 h, before they were incubated overnight with 100 nM TPA or vehicle only (DMSO). Cells were washed twice and stimulated with 100 ng/ml EGF for 5 min and lysed as described above. Transfection efficiency was monitored by Western blotting and by immunocytochemistry with relevant antibodies, namely, antibodies to Ha-Ras and HIS; cell lysates with equal levels of overexpression in Ras, GRD or CSRD þ GRD, for example, for Ras Figure 4a , lanes 4-12, were then processed for affinity precipitation of activated Ras from equal amounts of protein, using as bait a fusion protein of GST and the Ras-binding domain of c-Raf (GST-cRaf-1-RBD), which specifically recognizes activated Ras (de Rooij and Bos, 1997; Edamatsu et al., 1998) . In short, lysates were incubated with freshly prepared GST-c-Raf-1-RBD, conjugated to glutathione-sepharose beads (1 h at 41C). The GST-RBD-agarose beads were washed extensively, and the amounts of activated Ras precipitated by RBD (i.e., Figure 4b ) were determined, after SDS-PAGE on 15% gels, by Western analysis with Ha-Ras antibodies.
Establishment of a C6 astrocytoma cell line stably expressing the N-terminus of neurofibromin (CSRD þ GRD) C6 astrocytoma cells were transfected with the plasmid pcDNA3.1myc/HIS/CSRD þ GRD, which also contains a neomycin resistance gene. Cells were transfected using the Qiagen Transfection Reagent Selector Kit, as per manufacturer's instructions. After 2 days, cultures were exposed to 800 mg/ml neomycin sulfate for selection of resistant cells. For these studies we used a mix of three clonal cell lines with levels of expression of three-to fivefold, as evaluated by Western blot analysis of cell lysates immunoprecipitated with a monoclonal antibody to HIS. The antibiotic selection was removed after three passages and cells were cultured in normal medium. Reselection was performed for 2 days with 800 mg/ml neomycin sulfate every four culture passages.
Immunocytochemistry and measurement of fluorescent signal of each immunostained cell Cells grown on four-chamber-slides were processed for immunocytochemistry, as previously described (Cheng et al., 2000b; Li et al., 2001) . Briefly, cells were fixed with 3% paraformaldehyde (PFA) for 30 min, and non-specific sites were blocked with 5% normal goat serum. To visualize Ras content, cells were then incubated with a monoclonal against Ras (1:200) and, after several rinses, with a goat-anti-mouse secondary antibody conjugated to rhodamine. Nuclear DNA was stained with 4/6/-diamidino-2-phenylindole (DAPI; Pharmingen). Fluorescent images were visualized with a Leica fluorescent microscope DM 900. Digital images were captured with a highly sensitive cool (À251C) charged coupled device (CCD) camera (SPOT) controlled with the Spot Advanced (Diagnostic Instruments, Inc). Exposure time of 2 s, resembled best the optical microscope image of endogenous Ras ( Figure  6a and c) ; however, with this exposure immunofluorescence of Ras-overexpressing cells was beyond the linear range of the camera. Therefore, the exposure time for all imaging was adjusted to 1 s with zero Gain (i.e., Figure 6c 0 , e and g) so that the brightest signal (Ras overexpressing cells) in the specimen gave less than 95% of the maximum linear range for the camera (a grayscale of 0-4095; 12 bit grayscale). The same field was then imaged for DAPI signal and the two fluorescence signals from each field were merged using Spot Advanced image analysis features to facilitate identification of the nuclear status of transfected and untransfected cells. Cells were identified as quiescent or mitotic based upon DNA (DAPI signal) arrangement in chromosomes (Raucher and Sheetz, 1999; Crespo et al., 2002; Yamashiro et al., 2003) . Specifically, cells were considered as in mitosis when they possessed features characteristic of mitotic phases: condensed chromatin (prophase), chromosomes aligned on a central axis single band (metaphase), chromosomes being pulled toward the poles appearing as two bands (anaphase), two bands plus cell cleavage (telophase), or DNA at the poles with almost separated cytoplasm (cytokinesis).
More than 800 cells were photographed and analyzed from each experiment for a total of three experiments. Images saved in TIFF format, and the average fluorescence intensity in each of 300 cells/experiment were analyzed using NIH Image J 1.22.
Statistics
All experiments were performed 4-15 times with similar results and numerical data were analyzed by ANOVA.
Abbreviations PKC, protein kinase C; PLC, phospholipase C; PKA, protein kinase A; PAGE, polyacrylamide gel electrophoresis; PCR, polymerase chain reaction; ERK, extracellular signal-regulated kinase; AAX, A is an aliphatic amino acid, and X is serine, methionine, glutamine, or cysteine.
